85 related articles for article (PubMed ID: 33130349)
1. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
[TBL] [Abstract][Full Text] [Related]
2. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S
Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522
[TBL] [Abstract][Full Text] [Related]
3. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Zhang L; Liu P; Jiang Y; Fan D; He X; Zhang J; Luo B; Sui J; Luo Y; Fu X; Yang T
Eur J Med Chem; 2024 Jun; 272():116448. PubMed ID: 38704936
[TBL] [Abstract][Full Text] [Related]
4. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of New
Farghaly TA; Pashameah RA; Bayazeed A; Al-Soliemy AM; Alsaedi AMR; Harras MF
Med Chem; 2024; 20(1):63-77. PubMed ID: 37723960
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of ring-A modified lupeol derivatives and their anti-proliferative activity: identification of potent lead active against MCF-7 breast cancer cells.
Narendar K; Mandha Chander P; Abhisheik Eedara C; Andugulapati SB; Ramalingam V; SureshBabu K; Vijayachari P
Nat Prod Res; 2024; 38(2):304-310. PubMed ID: 36083601
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2,2-dimethyl-chroman-based stereochemically flexible and constrained anti-breast cancer agents.
Nainawat KS; Gupta K; Gupta N; Singh R; Mishra D; Nirwan A; Verma M; Singh A; Vasudev PG; Khan F; Mishra DP; Gupta A
Bioorg Med Chem Lett; 2024 Aug; 108():129789. PubMed ID: 38729318
[TBL] [Abstract][Full Text] [Related]
10. 2-Acetyl-5,8-dihydro-6-(4-methyl-3-pentenyl)-1,4-naphthohydroquinone-Derived Chalcones as Potential Anticancer Agents.
Maldonado J; Oliva A; Molinari A; Acevedo W
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894650
[TBL] [Abstract][Full Text] [Related]
11. Green Synthesis of a Novel Phytoalexin Derivative:
Roy LD; Kumar J
Anticancer Agents Med Chem; 2024; 24(1):66-76. PubMed ID: 37936468
[TBL] [Abstract][Full Text] [Related]
12. Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity Study.
Shah U; Patel N; Patel M; Rohit S; Solanki N; Patel A; Patel S; Patel V; Patel R; Jawarkar RD
Chem Biodivers; 2024 Jun; 21(6):e202301903. PubMed ID: 38623839
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bioassay of 3-Aryl -1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]- triazin-4(3H)-ones as anti-cancer agents.
Thaher BA; Al-Masri I; Wahedy K; Morjan R; Aliwaini S; Al Atter IM; Elmabhouh AA; Ibwaini AKA; Alkhaldi SL; Qeshta B; Jacob C; Deigner HP
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1797-1810. PubMed ID: 36856800
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic, Apoptosis-Inducing Activities, and Molecular Docking of a New Sterol from Bamboo Shoot Skin
Abdelhameed RFA; Nafie MS; Ibrahim AK; Yamada K; Abdel-Kader MS; Ibrahim AK; Ahmed SA; Badr JM; Habib ES
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266171
[TBL] [Abstract][Full Text] [Related]
15. Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I.
Wu G; Zhong H; Wang Y; Chen L; Sun J
Bioorg Med Chem; 2023 Dec; 96():117530. PubMed ID: 37956506
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of electron-rich curcumin analogues.
Amolins MW; Peterson LB; Blagg BS
Bioorg Med Chem; 2009 Jan; 17(1):360-7. PubMed ID: 19019687
[TBL] [Abstract][Full Text] [Related]
17. Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles.
Guo H; Tian Y; Wu X; Tu L; Liu J; Zheng Y; Huang R
Bioorg Chem; 2024 May; 146():107289. PubMed ID: 38493636
[TBL] [Abstract][Full Text] [Related]
18. Anti-lung Cancer Activity of Synthesized Substituted 1,4-Benzothiazines: An Insight from Molecular Docking and Experimental Studies.
Amin A; Khazir ZU; Ji A; Bhat BA; Murtaza D; Hurrah AA; Bhat IA; Parveen S; Nisar S; Sharma PK
Anticancer Agents Med Chem; 2024; 24(5):358-371. PubMed ID: 37957911
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling.
Jannuzzi AT; Yilmaz Goler AM; Shilkar D; Mondal S; Basavanakatti VN; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biol Drug Des; 2023 Nov; 102(5):1133-1154. PubMed ID: 37537000
[TBL] [Abstract][Full Text] [Related]
20. Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of
Iqbal S; Farhanaz ; Roohi ; Zaheer MR; Shankar K; Hussain MK; Zia Q; Rehman MT; AlAjmi MF; Gupta A
J Biomol Struct Dyn; 2024 Apr; 42(6):3145-3165. PubMed ID: 37227775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
